Fig. 4.
Fig. 4. Peripheral blood neutrophil counts in wild type, G-CSF−/−, G-CSF−/−/GM-CSF−/− and G-CSF−/−/IL-6−/− mice treated with C albicans. / Peripheral blood neutrophil levels in wild type, G-CSF−/−, G-CSF−/−/GM-CSF−/−and G-CSF−/−/ IL-6−/−mice at baseline (empty bars) and 7 days after candida infection (shaded bars), sampled identically. Data are represented as mean ± SD. *There was a significant difference in the neutrophil count on day 7 compared to day 0 for each genotype of mice (P < .05).

Peripheral blood neutrophil counts in wild type, G-CSF−/−, G-CSF−/−/GM-CSF−/− and G-CSF−/−/IL-6−/− mice treated with C albicans.

Peripheral blood neutrophil levels in wild type, G-CSF−/−, G-CSF−/−/GM-CSF−/−and G-CSF−/−/ IL-6−/−mice at baseline (empty bars) and 7 days after candida infection (shaded bars), sampled identically. Data are represented as mean ± SD. *There was a significant difference in the neutrophil count on day 7 compared to day 0 for each genotype of mice (P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal